EXACT Sciences Corporation (EXAS) — Capital Reinvestment Ratio
EXACT Sciences Corporation (EXAS) has a Capital Reinvestment Ratio of 0.21x as of December 2025, meaning it reinvests 0% of its operating cash flow ($151.69 Million) in capital expenditures ($31.24 Million). Check EXACT Sciences Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
EXACT Sciences Corporation Capital Reinvestment Ratio (2020–2025)
This chart tracks EXACT Sciences Corporation's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see EXAS cash generation efficiency.
Annual Capital Reinvestment Ratio for EXACT Sciences Corporation (2020–2025)
Year-by-year Capital Reinvestment Ratio for EXACT Sciences Corporation from 2020 to 2025. See EXAS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | $491.44 Million | $134.66 Million | ▼ -57.6% |
| 2024 | 0.65x | $210.54 Million | $135.99 Million | ▼ -18.8% |
| 2023 | 0.80x | $156.12 Million | $124.19 Million | ▲ +68.7% |
| 2020 | 0.47x | $136.48 Million | $64.35 Million | — |